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Abstract: 
This study monitored structural shifts of gut microbiota of rats developing precancerous mucosal 
lesions induced by carcinogen 1,2-dimethyl hydrazine (DMH) treatment using PCR-denaturing 
gradient gel electrophoresis (DGGE) and 454 pyrosequencing on the 16S rRNA gene V3 region. 
Partial least square discriminant analysis of DGGE fingerprints showed that the gut microbiota 
structure of treated animals was similar to that of the controls 1 and 3 weeks after DMH 
treatments, but significantly different 7 weeks after DMH treatments, when a large number of 
aberrant crypt foci (ACF) developed in their colons. Martens' uncertainty test, followed by anova 
test (P<0.05) identified Ruminococcus-like and Allobaculum-like bacteria as key variables for 
discrimination of DMH-treated rats from controls. Real-time PCR confirmed the significant 
increase of the Ruminococcus obeum and the Allobaculum-like bacteria in DMH-treated rats. 
UniFrac analysis based on V3 pyrosequencing further validated that the gut microbiota structures 
of treated and control animals were similar at an early stage, but segregated after ACF formation. 
Thirteen operational taxonomic units including Ruminococcus-like and Allobaculum-like 
bacteria were identified as key variables for the discrimination of DMH-treated rats from 
controls. Dynamic analysis of gut microbiota may become a noninvasive strategy for monitoring 
host health changes induced by carcinogen exposure. 
 
Article: 
INTRODUCTION 
The human and animal gastro-intestinal tract harbors a complex microbial community, which 
plays important roles in the host's physiology and pathology (Nicholson et al., 2005). Patients 
with inflammatory bowel disease, obesity, diabetes and colorectal cancer (CRC) have different 
gut microbial structural patterns compared with healthy populations (Guarner & Malagelada, 
2003; Ley et al., 2006; Cani et al., 2007; Turnbaugh et al., 2008). 
 
Dynamic monitoring of structural shifts of gut microbiota associated with disease predisposition 
and progression may lead to a deeper understanding of the relationship between gut microbiota 
and host health status and the discovery of new tools for early diagnosis and prevention (McGarr 
et al., 2005). 
 
Aberrant crypt foci (ACF) induced by 1,2-dimethyl hydrazine (DMH) has been established as a 
model for precancerous lesion formation in CRC development (McLellan & Bird, 1991). A 
previous study suggested that members of gut microbiota participated in the carcinogenic process 
by releasing conjugated DMH metabolites (Pozharisski et al., 1975; Likhachev et al., 1985). The 
mean number of aberrant crypts per focus in germ-free rats was less than conventionalized rats 
and activities of fecal bacterial enzymes such as β-glucuronidase and mucinase increased in rats 
with ACF, but decreased, followed by the reduced number of ACF after dietary modulation such 
as caraway treatment, suggesting that gut microbiota is related to ACF formation induced by 
DMH (Onoue et al., 1997; Deeptha et al., 2006). In this study, we use this model to study the 
dynamic structural shifts of gut microbiota in association with host health changes at different 
time points after DMH treatment in an attempt to develop novel health monitoring methods with 
gut microbiota as the primary target. 
 
MATERIALS AND METHODS 
Animal treatment and DNA extraction 
All of the animal studies were performed under relevant national legislation and local guidelines. 
Twelve Wistar rats (male, 90±10 g) were purchased from Shanghai Laboratory Animal Co. Ltd, 
China, and kept in an SPF barrier system with controlled temperature (20.0±0.5 °C) and 
humidity (60±10%), and fed with a certified standard rat chow and tap water ad libitum. 
 
After 1 week of acclimatization, the rats were divided randomly into two groups: the model 
group (n=6) received a subcutaneous injection with a DMH (Sigma, St. Louis, MO) solution at a 
dose of 30 mg kg−1 body weight, on the first day and 1 week after acclimatization separately. 
The DMH solution was prepared in 25 mM EDTA/137 mM NaCl carrier (pH 6.4) and the 
control group (n=6) received a subcutaneous injection with the same volume of EDTA/NaCl 
carrier. Fresh feces were collected 1 week (T1), 3 weeks (T2) and 7 weeks (T3) after the second 
injection and stored at −20 °C for further analysis. Animals' food consumption was monitored 
during the entire experiment. On the first day of the 10th week, all animals were weighed and 
sacrificed by decapitation after halothane anesthesia, the spleen was weighed and the entire colon 
was removed for ACF counting (Onoue et al., 1997). The identification of ACF was based on a 
method described previously (Deeptha et al., 2006). Briefly, fixed colons (10% buffered 
formalin) were stained in a 0.2% solution of methylene blue and then examined under a 
microscope for ACF counting. Food consumption, and the final body and spleen weights of each 
group were compared using Student's t-test. 
 
DNA was extracted from each fecal sample based on the bead-beating method as described 
previously (Zoetendal et al., 2002). 
 
Primers and PCR amplification 
The V3 region of the 16S rRNA gene from each DNA sample was amplified with universal 
primers P3 (5′-
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGCCTACGGGAGGCAGC
AG-3′) and P2 (5′-ATTACCGCGGCTGCTGG-3′), using the hot-start touchdown protocol 
described before (Muyzer et al., 1993) for denaturing gradient gel electrophoresis (DGGE) 
analysis. Each 25 μL PCR reaction mixture contained 1.5 U of rTaq DNA polymerase, 2 mM 
MgCl2, 2.5 μL of the corresponding 10 × buffer (Takara, Dalian, China), 200 μM each dNTP, 
12.5 pmol of each primer and 20 ng of total DNA template, and was conducted in a thermocycler 
PCR system (PCR Sprint, Thermo electron, UK). A five-cycle reconditioning PCR method was 
performed in order to decrease heteroduplex formation (Thompson et al., 2002). 
 
DNA extracted from fecal samples collected at T1 and T3 were used in 454 pyrosequencing. The 
same gene fragment was amplified with the forward primer 5′-
NNNNNNNNATTACCGCGGCTGCT-3′ and the reverse primer 5′-
NNNNNNNNCCTACGGGAGGCAGCAG-3′. The NNNNNNNN was the unique eight base 
barcode used to distinguish PCR product from different samples and the underlined texts meant 
the nucleotide sequences of both primers. Each of the primer pairs contained a sample-unique 
barcode. PCR reactions were performed as described before (Zhang et al., 2010). 
 
DGGE analysis of the 16S rRNA gene V3 region 
DGGE was performed using a Dcode System apparatus (Bio-Rad, Hercules, CA). PCR products 
(200 ng) were separated on 8% w/v polyacrylamide gels with a 26.5–52% denaturant gradient 
(100% denaturant was 7 M urea and 40% deionized formamide). Electrophoresis was performed 
in 1 × Tris-acetate-EDTA buffer at 200 V (constant voltage) and 60 °C for 4 h. The gels were 
stained with SYBR Green I (Amresco, Solon, Ohio) and were photographed using a UVI gel 
documentation system (UVItec, Cambridge, UK). 
 
The intensity and mobility of each band were analyzed using the software quantity one® v4.4 
(Bio-Rad, Herts, UK). 
 
Important DGGE bands were excised from the gel under UV illumination and incubated in 
100 μL of Tris-EDTA buffer (pH 8.0) overnight at 4 °C. Supernatant (1 μL) was used as a 
template for reamplication of the sequence with primers P2 and P3 as described above. The PCR 
products were purified using the PCR clean-up kit (V-gene, Hangzhou, China), ligated into the 
pGEM-T Easy Vector (Promega, Madison, WI) and electrotransformed into competent 
Escherichia coli DH5α cells. Positive clones were picked out randomly, and inserts were 
reamplified and screened by DGGE to verify their migration positions. Clones that migrated to 
the same positions as the original DGGE bands were sequenced (Invitrogen, Shanghai, China). 
 
Pyrosequencing of the 16S rRNA gene V3 region 
The PCR product from each sample was purified using the Gel/PCR DNA Fragments Extraction 
Kit (Geneaid, UKAS). Thirty nanogram of each purified PCR product was mixed and purified 
from a 1.2% agarose gel using the Gel/PCR DNA Fragments Extraction Kit (Geneaid, UKAS) 
and used as the DNA library for pyrosequencing with a GS20 platform (Roche) (Margulies et al., 
2005). Good-quality sequences were selected using the same protocol as described previously 
(Zhang et al., 2010) and were used in the following analysis. 
 
 
Bioinformatic and statistical analysis of DGGE and pyrosequencing 
All unique sequences from pyrosequencing were aligned using the NAST multi-aligner with a 
minimum template length of 100 bases and a minimum percent identity of 75% (DeSantis et al., 
2006). The resulting alignments were imported into the arb (Ludwig et al., 2004) to calculate the 
distance matrix. The distance matrix was then imported into dotur for phylotype binning (Schloss 
& Handelsman, 2005) and operational taxonomic units (OTUs) were defined using a threshold of 
97% identity (Huse et al., 2007). The rarefaction curve (Hammer et al., 2001) and the Shannon 
Diversity Index (http://www.r-project.org/) were calculated for each library. One sequence 
randomly selected from each OTU was inserted into pre-established phylogenetic trees of full-
length 16S rRNA gene sequences' database from GreenGenes using arb (hypervariable regions 
masked with the lanemaskPH filter) to construct a neighbor-joining tree (Ludwig et al., 2004). 
This phylogenetic tree was then used for online UniFrac 
(http://bmf2.colorado.edu/unifrac/index.psp) with abundance weighting. 
 
Principal component analysis (PCA) based on digitized DGGE patterns was used to compare the 
gut microbiota of treated rats and the controls at different time points, and partial least square 
discriminant analysis (PLS-DA) established by related DGGE patterns or OTU abundance (X) to 
their corresponding treatment index (Y) (Wold et al., 1983) were used to discriminate two 
groups at T3. Leave-one-out cross-validation (LOOCV) was used to evaluate the correct 
classification rate of PLS-DA models (Osten, 1988) and Martens' uncertainty test, followed by 
one-way anova was used to select stable and significant X-variables (Westad & Martens, 2000). 
All statistical analyses were implemented under a matlab® (Version 7.1, The MathWorks Inc. 
Natick, MA) environment. 
 
Sequences of important DGGE bands and one sequence randomly selected from each important 
OTU were aligned to the Ribosomal Database Project (RDP, release 9.33) database to determine 
their closest phylogenetic relatives. A neighbor-joining phylogenetic tree based on these 
sequences was constructed using the Jukes–Cantor algorithm (Kumar et al., 2004) by mega 3.1 
software. Bootstrap resampling analysis based on 500 replicates was performed in order to 
estimate the degree of confidence in the tree topology. 
 
Real-time quantitative PCR (RT-qPCR) 
Plasmids containing the Ruminococcus obeum 16S rRNA gene fragment and the fragment 
recovered from the V3-28 DGGE bands were prepared separately using the QIAGEN Plasmid 
Mini Kit (Qiagen, Hilden, Germany) and diluted from 1.23 × 103 to 1.23 × 109 (copies μL−1) 
separately to construct standard curves. 
 
RT-qPCR targeting R. obeum was performed with the species-specific primers ROB3 (5′-
TGAGGAGACTGCCAGGGA-3′) and ROB2 (5′-CTCCTTCTTTGCAGTTAGGT-3′) (Wang et 
al., 1997). The 25 μL reaction mixture contained 1.5 U rTaq DNA polymerase (Takara), 12.5 μL 
of 2 × SYBR Green I mix (Shanghai Biocolour BioScience & Technology Company), 12.5 pmol 
of each primer and 20 ng of DNA from each sample or 1 μL of standard plasmid. The reaction 
was performed using a DNA Engine Opticon 3 system (MJ Research) with the following 
program: an initial denaturation step at 94 °C for 3 min; 40 cycles of 94 °C for 30 s, 59 °C for 
30 s and 72 °C for 30 s; and a final extension at 72 °C for 10 min. At the end of each cycle, the 
fluorescent signal was measured at 82 °C. The melting curves were obtained by slow heating at 
0.5 °C s−1 increments from 70 to 95 °C with continuous fluorescence collection. Each sample 
had three replicates. 
 
RT-qPCR targeting bacteria represented by V3-28 was performed with the primer pair v328-FP 
(5′-GGCGAGGTACCATCAAAACG-3′), v328-RP (5′-TCGGGTCGTAAAGCTCTGTTG-3′) 
and TaqMan probe : 5 ′ FAM-TCATTTCCTCTTCCGTTCCTTTTT- TAMRA 3 ′ (Invitrogen) . 
Both the primers and the probe were designed based on fragment sequence using primer express 
software Version 2.0 (Applied Biosystems) and verified for specificity by comparison against the 
RDP (release 9.33) database. The 25 μL reaction mixture contained 1.75 U rTaq DNA 
polymerase, 2.5 μL of 10 × buffer, 2 mM MgCl2 (Takara), 200 μM of each dNTP, 12.5 pmol of 
each primer and TaqMan probe and 20 ng of DNA from each sample or 1 μL of standard 
plasmid. The reaction was performed as described above, with the only difference that the 
fluorescent signal was measured at 72 °C at the end of each cycle. 
 
The data detected by the system were analyzed using the opticon monitor Software (Version 3.1) 
and the quantities of these bacteria in different animals were compared using the one-way anova 
test. 
 
Nucleotide sequence accession numbers 
The sequences obtained from DGGE bands and unique sequences from pyrosequencing in this 
study are available in the GenBank database under accession numbers EF062467–EF062468 and 
GU577113–GU580655, respectively. 
 
RESULTS 
General observations and ACF counting 
All animals survived the entire course of the experiment. Food consumption of the control and 
the DMH treatment group was similar. There was no significant difference in the final body 
weight between the control group (313.9±19.0 g) and the DMH-treated group (304.9±15.9 g, 
P>0.05). No significant difference was observed in the final spleen weight between the control 
group (564.5±38.1 mg) and the DMH-treated group (556. 9±41.3 mg, P>0.05). During the 
experimental period, no obvious clinical signs were observed in both of the groups. 37.7±2.6 
ACF were detected in DMH-treated animals after 7 weeks, but none in any of the control 
animals. 
 
DGGE analysis 
PCR-DGGE fingerprinting analysis of DMH-treated and control rats for predominant bacteria 
was used to capture the structural response in gut microbiota during ACF formation (Fig. 1a–c). 
PCA score plots (PC1 vs. PC2) based on the PCR-DGGE fingerprint indicated that gut 
microbiota structures of the DMH-treated and the control rats showed no significant difference at 
T1 and a slight tendency towards separation at T2, but a very distinct segregation at T3 (Fig. 1d–
f). The PLS-DA model also indicated this obvious segregation at T3 (Supporting Information, 
Fig. S1). A PLS-DA model based on all DGGE bands yielded an 83% correct classification rate 
in LOOCV when one PLS component was used. Martens' uncertainty test, followed by the one-
way anova test (P<0.05) identified two DGGE bands (V3-22 and V3-28) as significant variables 
in the discrimination of treated rats from the controls (Fig. 1c), and these two bands also have 
high loadings on both PCA (PC1/PC2 loadings plot) and PLS-DA (Fig. S2). A new PLS-DA 
model established using these two important variables further yielded a 91% correct 
classification rate in LOOCV when one PLS component was used. 
 
 
Figure 1: Structural segregation analysis of gut microbiota in precancerous and healthy control 
rats. 
 
(a–c) 16S rRNA gene V3 region PCR-DGGE profiles of fecal samples obtained from healthy rats (control group) and DMH-treated rats (model 
group) at 1 week (T1), 3 weeks (T2) and 7 weeks (T3) after DMH treatments; (d–f) PC1 vs. PC2 scores plots of the PCR-DGGE profiles at T1, 
T2 and T3 between the control (open circle) and the model (solid circle) groups. M represents the marker for DGGE analysis. The DGGE marker 
was created by mixing 11 sequenced V3 fragments using the same primers. The identities of these 11 sequences are listed in Table S3. 
 
 
These two bands were identified by sequencing the eluted DNA as having 98% similarity to R. 
obeum (X85101) and 95% similarity to Allobaculum stercoricanis (AJ417075), respectively 
(Table 1). 
 
 
Table 1: Sequence identity of the discriminating DGGE bands between healthy control and 
DMH-induced precancerous rats 
Clone 
no. 
Accession 
no. 
Closely identified phylogenetic 
relatives (nearest or the next validly 
described taxon) 
Population trend in DMH-
treated rats compared with 
control rats 
Similarity 
(%) 
V3-22 EF062467 Ruminococcus obeum (X85101) ↑ 98 
V3-28 EF062468 Allobaculum stercoricanis (AJ417075) ↑ 95 
↑, Bacteria represented by this DGGE band were more abundant in DMH-treated rats. 
 
 
 
454 Pyrosequencing 
A total of 21 150 useable sequencing reads and 3543 unique sequences were obtained in all 
samples. The average number of reads of all samples was 881, with two samples having <500 
reads (Table S1). OTUs (509) were obtained under 97% identity (Table S2). The Shannon 
Diversity Index curves of all samples reached stable values, while all rarefaction curves still did 
not plateau with the current sequencing (Fig. 2). 
 
Figure 2: 
 
(a) Rarefaction analysis of sampling. Repeated samples of OTU subsets were used to evaluate whether further sampling would likely yield 
additional taxa, as indicated by whether the curve has reached a plateau value. (b) Shannon Diversity Index curves to estimate the diversity of 
taxa present in individual animals. Color code for each treatment group: black, control at T1; blue, control at T3; red, DMH-treated at T1; and 
green, DMH-treated at T3. 
 
Principal coordinate analysis (PCoA) plots of UniFrac analysis revealed a similar structure at T1 
and segregation at T3 between the two groups (Fig. 3). The PLS-DA score plot also showed this 
segregation (Fig. 4a). The PLS-DA model yielded a 58.33% correct classification rate in 
LOOCV with two PLS components. Martens' uncertainty test, followed by the one-way anova 
test (P<0.05) identified 13 OTUs (numbers 1, 26, 31, 35, 49, 53, 72, 98, 99, 123, 135, 163, 240) 
as key variables for classification in this model. A new PLS-DA model established using these 
13 OTUs further achieved a 91% correct classification rate in LOOCV with one PLS component. 
 
Figure 3: 
 
Weighted UniFrac PCoA plots of gut microbiota between the control and the model groups based on pyrosequencing data. A phylogenetic tree of 
randomly selected representative sequences from each OTU was used for UniFrac analysis. (a) Differences between the control (open triangle) 
and the model (solid triangle) groups at T1 (using first 2 components). (b) Differences between the control (open circle) and the model (solid 
circle) groups at T3 (using the first 2 components). 
 
Figure 4: 
 
(a) PLS-DA scores plot (PLS1–PLS2) based on pyrosequencing OTU (97%) data at T3 between the control (open circle) and the model (solid 
circle) groups. (b) Abundance distribution of 13 OTUs identified as key variables for discrimination between the control group (A–F) and the 
model group (G–L) at T3. To show the distribution of the OTUs with a lower abundance, the color squares of column have been scaled to 
indicate the relative ratios of each OTU among 12 rats. 
 
OTU 1 consisted of 120 sequences and OTU 26 consisted of 61 sequences, and were the first and 
the second most dominant OTUs. The representative sequence of OTU 1 was most closely 
related to R. obeum (L76601, 99.27% similarity) and also close to the sequence of the V3-22 
band in the phylogenetic tree. The representative sequence of OTU 26 was most closely related 
to A. stercoricanis (AJ417075, 93.86% similarity), and close to the sequence of the V3-28 band 
in the tree (Fig. 5). Both OTUs in DMH-treated rats were more abundant than in the controls at 
T3 (Fig. 4b). The phylogenies of the other 11 OTUs are shown in the tree (Fig. 5), and they were 
all less abundant in DMH-treated rats than in the controls at T3 (Fig. 4b). 
 
RT-qPCR 
Both standard curves of the two qPCR assays showed a good linearity. The PCR product length 
of the R. obeum species and the bacteria represented by the V3-28 band was 312 bp and 74 bp, 
respectively. 
 
The amount of R. obeum in DMH-treated group showed no difference from the controls at T1, 
and slightly increased at T2 without statistical significance, and significantly increased at T3 
(one-way anova, P<0.05) (Fig. 6a). 
  
Figure 5: 
 
Phylogenetic tree analysis of the discriminating OTUs, DGGE bands and their nearest neighbors from the RDP database, using the neighbor-
joining method by mega 3.1. One randomly selected representative sequence for each OTU was appended in the bracket. The bar represents 5% 
estimated sequence divergence. Bootstrap values are indicated at the branch nodes. 
 
 
 
Figure 6: 
 
Quantity of Ruminococcus obeum (a) and the bacteria represented by V3-28 band (b) between the control and the model rats at T1, T2 and T3 by 
RT-qPCR. Values are shown as means±SD (error bars).Values with asterisks show statistical significance compared with the others (P<0.05). 
 
The bacteria represented by V3-28 at T1 could not be detected in any sample, indicating a very 
low level. At T2, the amount of bacteria in DMH-treated group was slightly higher than that in 
the control group without statistical significance . At T3, it was significantly higher in the DMH-
treated group (one-way anova, P<0.05) (Fig. 6b). 
 
DISCUSSION 
Using PCR-DGGE and 454 pyrosequencing, combined with multivariate statistical methods, we 
demonstrated that the gut microbiota structure shifted during formation of colon precancerous 
lesions in DMH-induced rat models, and we further identified the significantly changed bacteria. 
 
Both the PCoA plots of pyrosequencing and the PCA scores plots of DGGE fingerprints 
indicated that the gut microbiota compositions were similar in DMH-treated rats and controls at 
T1, but significantly different at T3. PLS-DA further confirmed that the bacterial composition 
changed significantly between two groups at T3. Taking advantage of its ability to deal with 
multivariate datasets and to reveal the important variables in the model (Pérez-Enciso & 
Tenenhaus, 2003; Wang et al., 2005), PLS-DA has been demonstrated to be powerful in 
analyzing data from the DNA clone library (Zhang et al., 2009) and 454 pyrosequencing studies 
(Zhang et al., 2010). In this study, this methodology also identified key variables from massive 
datasets generated using different molecular techniques. In the 13 OTUs selected as key 
variables in pyrosequencing, the two most abundant ones were phylogenetically closely related 
to the sequences identified from the two key DGGE bands, indicating that PLS-DA is a robust 
statistical tool for analyzing datasets generated using different molecular methods. 
 
Compared with DGGE, 454 pyrosequencing provides a deeper and a more comprehensive 
description of the microbial diversity of a community (Zhang et al., 2010). In our study, the 
rarefaction analysis showed the potential underestimation of community diversity, as the curves 
did not plateau with the current sequencing effort. However, the Shannon Diversity curves of all 
samples had reached stable values. This means that most diversity has been captured by this 
sampling size (Sogin et al., 2006; McKenna et al., 2008). 
 
The relative abundance of Ruminococcus-related bacteria was identified by both DGGE and 
pyrosequencing as being significantly higher in rats with precancerous lesions compared with 
healthy ones. RT-PCR further confirmed that the amount of R. obeum was higher in rats with 
precancerous lesions. This is consistent with a previous study on human commensal 
Ruminoccocus species, showing that Ruminoccocus species were more frequently isolated from 
high-risk populations with CRC (Moore & Moore, 1995). The underlying mechanisms are yet to 
be elucidated. 
 
Some OTUs closely related to Clostridium species and Coprococcus catus were identified as key 
variables in distinguishing rats with precancerous lesions from healthy ones. The Clostridium 
herbivorans-, Clostridium populeti- and Clostridium sporosphaeroides-related OTUs (OTU 31, 
35, 98) and C. catus-related OTU 240 were demonstrated to be less abundant in the DMH-
treated rats with precancerous lesions compared with controls. A few Clostridium and 
Coprococcus species are known to play positive roles in host health by producing butyrate, 
acetate and other short-chain fatty acids (SCFAs) (Pryde et al., 2002). SCFAs have long been 
known to play important roles in maintaining colonic health (Mortensen & Clausen, 1996), with 
butyrate having the most noticeable effects on protecting colonic epithelial health and preventing 
colorectal carcinogenesis. Butyrate has been demonstrated to influence gene expression, induce 
apoptosis in cancer cell lines and inhibit the genotoxic effect of nitrosamides and hydrogen 
peroxide in human colon cells (Wollowski et al., 2001; Pryde et al., 2002). In this study, the lack 
of these bacteria in DMH-treated rats with precancerous lesions may result in less protection 
against colon cancer. 
 
Various Bifidobacterium species have been shown to exert a probiotic action against the 
occurrence of colon cancer (Ljungh & Wadström, 2006). The abundance of Bifidobacterium 
choerinum-related OTU 123 was also lower in DMH-treated rats with precancerous lesions. 
Bifidobacterium choerinum was indicated as a potential probiotic (Maxwell et al., 2004). The 
lower abundance of B. choerinum-like bacteria in rats with precancerous lesions may also lead to 
less protection from colon cancer. 
 
The structural divergence of gut microbiota in DMH-treated animals away from healthy controls 
over time may be resulting from a direct effect of DMH on gut bacteria or from DMH-induced 
changes in the host during the formation of precancerous lesions in the colon. The half-life of 
DMH and its metabolites in the host were about several hours (Pozharisskii&#x030c;et al., 
1976). Thus, the amount of DMH and its metabolites may become negligible in the host at T1 
and T2. Previous studies based on similar DMH-induced precancerous rat models showed that 
epithelial hyperplasia of colonic mucosal glands (Decaens et al., 1983), and increased apoptosis 
and mitosis in colonic crypt epithelium (Smith et al., 2003) were observed at the time point 
similar to T1 in our experiment. Another study showed that ACF formation in rat colon was 
observed at the time point similar to T2 in our experiment (Ishizuka et al., 1996). In our study, 
gut microbiota in DMH-treated rats showed no difference from controls at T1, a slight difference 
at T2 and significant segregation at T3. Gut microbiota does not change significantly when the 
host begins to show the physiological changes induced by DMH. The structural segregation of 
gut microbiota concomitant with ACF formation may be a result of DMH-induced changes of the 
host rather than a direct toxicity effect of DMH on gut microbiota. 
 
ACF is widely accepted as precancerous lesions in the colon of animals and humans (Pretlow et 
al., 1991; Bird & Good, 2000). However, animals with a large number of ACF in their colon are 
still apparently healthy, while global profiling of their fecal microbiota revealed that, compared 
with healthy animals, significant segregation of gut microbial composition already occurred in 
their gut. This is an indication that gut microbiota structure may be a sensitive surrogate endpoint 
for host health. In addition, monitoring of the gut microbiota structure is easy and noninvasive to 
the host. Dynamic monitoring of the structural segregation of gut microbiota away from the 
healthy majority may become a useful tool for pinpointing individuals whose health status 
indicates underlying significant, but still early changes such as the development of precancerous 
lesions of CRC induced by environmental perturbations. 
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